https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/hepatitis-c

The Latest

Hep C virus

This Week in HIV Research: Hep C, That Other Epidemic Within an Epidemic

Sept. 3, 2020: A hepatitis C microelimination program for people living with HIV; PrEP concentrations and gender-affirming hormones; a collaborative intervention to improve opioid prescribing practices; TDF and fracture risk.

By Barbara Jungwirth and Myles Helfand
Annette Gaudino and Bryn Gay

With Several Curative Therapies for Hepatitis C on the Market, the Research Pipeline for Prevention Continues

The authors of an influential annual report on hepatitis C research and development talk through what's new and evolving in clinical science.

By Terri Wilder, M.S.W.
mouth to ear

This Week in HIV Research: Why Aren’t We Listening to Ourselves?

Aug. 13, 2020: HCV testing rates among people newly diagnosed with HIV; HCV treatment referrals ammong coinfected people; HIV mortality rates despite free treatment access; mysterious, plummeting CD4 test results.

By Barbara Jungwirth and Myles Helfand
COVID-19 patient care-iStock-1218539192

Can Drugs That Cure Hepatitis C Treat COVID-19? Here’s the State of the Research So Far.

An interview with Andrew Hill, Ph.D., about his research presented at AIDS 2020.

By Terri Wilder, M.S.W.
mental connection

This Week in HIV Research: The Mind Matters

July 23, 2020: Depression and HIV risk mitigation among MSM; a consistent HIV provider is good for CD4 and viral load; spirituality and HIV prevention; HCV treatment access and reinfection risk.

By Barbara Jungwirth and Myles Helfand
long road ahead

This Week in HIV Research: Do As We Say, Not As We Do

July 9, 2020: Abysmal HIV testing rates in U.S. ambulatory care settings; STI testing frequency in PrEP users; trends in U.S. PrEP uptake; integrating opioid therapy with HCV care in people who inject drugs.

By Barbara Jungwirth and Myles Helfand
organ transplant transport

New HIV, Hepatitis B and C Guidelines Will Make More Organs Available for Transplant, Experts Say

A revolution in organ transplants is taking place.

By Martha Kempner
Suraj Madoori, M.P.H., M.S.J., M.A. and Annette Gaudino

Will We Ever Have a Hepatitis C Vaccine? Two Activists Weigh in on the Challenges and Opportunities Ahead

A new injection of funding from Congress could be the catalyst for a future hepatitis C (HCV) vaccine.

By Terri Wilder, M.S.W.
snowball

This Week in HIV Research: HIV/COVID-19 Case Studies Gain Momentum

June 4, 2020: The latest on COVID-19 hospitalization among people with HIV; real-world success of hepatitis C treatment in coinfected patients with good health care; poverty and adherence in Canada's health system; demographic and socioeconomic factors associated with viral rebound.

By Barbara Jungwirth and Myles Helfand
data

This Week in HIV Research: There’s No Such Thing as Too Much Data

May 7, 2020: Epidemiological factors among transgender women; revised PrEP indication estimates for MSM; trends in HIV strain similarity between younger and older MSM; current hepatitis C epidemic among British MSM with HIV.

By Barbara Jungwirth and Myles Helfand